Coronary artery bypass surgery CABG in left ventricular dysfunction

Coronary Artery Bypass Surgery Microchapters
Home
Patient Information
Overview
Pathophysiology
Saphenous Vein Graft Disease
Other Non-Atherosclerotic Saphenous Vein Graft Diseases
Indications for CABG
Prognosis
Diagnosis
Imaging in the Patient Undergoing CABG
Chest X Ray
Angiography
CT Angiography
MRI Angiography
Trans-Esophageal Echocardiography
Treatment
Goals of Treatment
Perioperative Management
Perioperative Monitoring
Electrocardiographic Monitoring
Pulmonary Artery Catheterization
Central Nervous System Monitoring
Surgical Procedure
Anesthetic Considerations
Intervention in left main coronary artery disease
The Traditional Coronary Artery Bypass Grafting Procedure (Simplified)
Minimally Invasive CABG
Hybrid coronary revascularization
Conduits Used for Bypass
Videos on Spahenous Vein Graft Harvesting
Videos on Coronary Artery Bypass Surgery
Post-Operative Care and Complications
Pharmacotherapy in patients undergoing CABG CABG
Special Scenarios
Anomalous Coronary Arteries
COPD/Respiratory Insufficiency
Existing Renal Disease
Concomitant Valvular Disease
Previous Cardiac Surgery
Menopause
Carotid Disease evaluation before surgery
Coronary artery bypass surgery CABG in left ventricular dysfunction On the Web
Most recent articles
Most cited articles
Review articles
CME programs
powerpoint slides
Images
Ongoing trials at clinical trials.gov
US National guidelines clearinghouse
NICE guidance
FDA on Coronary artery bypass surgery CABG in left ventricular dysfunction
CDC on Coronary artery bypass surgery CABG in left ventricular dysfunction
Coronary artery bypass surgery CABG in left ventricular dysfunction in the news
Blogs on Coronary artery bypass surgery CABG in left ventricular dysfunction|-
Directions to Hospitals Performing Coronary artery bypass surgery CABG in left ventricular dysfunction
Risk calculators for Coronary artery bypass surgery CABG in left ventricular dysfunction

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

CABG in left ventricular dysfunction

It has not been clearly established whether CABG palys a significant role in treatment of heart failure. In the STICH trial of 1212 patients each with ejection fraction < 35 % and coronary artery disease requiring CABG, there was no statistically significant difference between medical therapy alone versus medical therapy along with CABG in terms of primary end point of death from any cause.